Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,109 |
Reported balance
After 2026-03-18 transaction · row 1
1 source rowRow 1 · 2026-03-18 · Grant · Acquired 1,800 · Balance 35,109 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 16, 2021 Filed Sep 10, 2021 21:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 15 | $3.03 | $45.45 |
DisclosureSEC source: 0001209191-21-055488 · doc4.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,948 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Read SEC document |
| March 17, 2021 Filed Jun 11, 2021 21:23 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | GrantCommon Stock | 1,000 | $3.22 | $3,220.00 |
DisclosureSEC source: 0001209191-21-039938 · doc4.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,933 F1 · shares: Restricted stock award will vest 100% on March 17, 2022. Read SEC document |
| December 22, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 10 | $3.13 | $31.30 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 28 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,933 Read SEC document |
| December 21, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.15 | $47.25 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 27 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,923 Read SEC document |
| December 18, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.17 | $47.55 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 26 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,908 Read SEC document |
| December 17, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.13 | $46.95 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 25 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,893 Read SEC document |
| December 16, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.03 | $45.45 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 24 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,878 Read SEC document |
| December 15, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.03 | $45.45 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 23 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,863 Read SEC document |
| December 14, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.04 | $45.60 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 22 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,848 Read SEC document |
| December 11, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.04 | $45.60 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 21 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,833 Read SEC document |
| December 10, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.05 | $45.75 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 20 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,818 Read SEC document |
| December 09, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.03 | $45.45 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 19 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,803 Read SEC document |
| December 08, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.05 | $45.75 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 18 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,788 Read SEC document |
| December 07, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.01 | $45.15 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 17 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,773 Read SEC document |
| December 04, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.02 | $45.30 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 16 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,758 Read SEC document |
| December 03, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.02 | $45.30 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 15 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,743 Read SEC document |
| December 02, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.03 | $45.45 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 14 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,728 Read SEC document |
| December 01, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.01 | $45.15 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 13 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,713 Read SEC document |
| November 30, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.05 | $45.75 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 12 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,698 Read SEC document |
| November 27, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $2.99 | $44.85 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 11 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,683 Read SEC document |
| November 25, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.01 | $45.15 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 10 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,668 Read SEC document |
| November 24, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.03 | $45.45 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 9 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,653 Read SEC document |
| November 23, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.03 | $45.45 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 8 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,638 Read SEC document |
| November 20, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.02 | $45.30 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 7 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,623 Read SEC document |
| November 19, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $2.98 | $44.70 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 6 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,608 Read SEC document |
| November 18, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.01 | $45.15 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 5 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,593 Read SEC document |
| November 17, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $2.96 | $44.40 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 4 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,578 Read SEC document |
| November 16, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.05 | $45.75 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 3 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,563 Read SEC document |
| November 13, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.04 | $45.60 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 2 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,548 Read SEC document |
| November 12, 2020 Filed Feb 5, 2021 23:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.03 | $45.45 |
DisclosureSEC source: 0001209191-21-008280 · doc5.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,533 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. F2 · shares: Filing 6 of 6 Read SEC document |
| November 11, 2020 Filed Feb 5, 2021 23:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.12 | $46.80 |
DisclosureSEC source: 0001209191-21-008276 · doc5.xml · nonDerivative · entry 30 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,518 Read SEC document |
| November 10, 2020 Filed Feb 5, 2021 23:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.09 | $46.35 |
DisclosureSEC source: 0001209191-21-008276 · doc5.xml · nonDerivative · entry 29 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,503 Read SEC document |
| November 09, 2020 Filed Feb 5, 2021 23:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.06 | $45.90 |
DisclosureSEC source: 0001209191-21-008276 · doc5.xml · nonDerivative · entry 28 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,488 Read SEC document |
| November 06, 2020 Filed Feb 5, 2021 23:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $2.99 | $44.85 |
DisclosureSEC source: 0001209191-21-008276 · doc5.xml · nonDerivative · entry 27 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,473 Read SEC document |
| November 05, 2020 Filed Feb 5, 2021 23:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $2.98 | $44.70 |
DisclosureSEC source: 0001209191-21-008276 · doc5.xml · nonDerivative · entry 26 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,458 Read SEC document |
| November 04, 2020 Filed Feb 5, 2021 23:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.01 | $45.15 |
DisclosureSEC source: 0001209191-21-008276 · doc5.xml · nonDerivative · entry 25 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,443 Read SEC document |
| November 03, 2020 Filed Feb 5, 2021 23:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $2.99 | $44.85 |
DisclosureSEC source: 0001209191-21-008276 · doc5.xml · nonDerivative · entry 24 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,428 Read SEC document |
| November 02, 2020 Filed Feb 5, 2021 23:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $2.97 | $44.55 |
DisclosureSEC source: 0001209191-21-008276 · doc5.xml · nonDerivative · entry 23 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,413 Read SEC document |
| October 30, 2020 Filed Feb 5, 2021 23:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $2.99 | $44.85 |
DisclosureSEC source: 0001209191-21-008276 · doc5.xml · nonDerivative · entry 22 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,398 Read SEC document |
| October 29, 2020 Filed Feb 5, 2021 23:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.02 | $45.30 |
DisclosureSEC source: 0001209191-21-008276 · doc5.xml · nonDerivative · entry 21 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,383 Read SEC document |
| October 28, 2020 Filed Feb 5, 2021 23:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $2.97 | $44.55 |
DisclosureSEC source: 0001209191-21-008276 · doc5.xml · nonDerivative · entry 20 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,368 Read SEC document |
| October 27, 2020 Filed Feb 5, 2021 23:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.06 | $45.90 |
DisclosureSEC source: 0001209191-21-008276 · doc5.xml · nonDerivative · entry 19 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,353 Read SEC document |
| October 26, 2020 Filed Feb 5, 2021 23:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.02 | $45.30 |
DisclosureSEC source: 0001209191-21-008276 · doc5.xml · nonDerivative · entry 18 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,338 Read SEC document |
| October 23, 2020 Filed Feb 5, 2021 23:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.04 | $45.60 |
DisclosureSEC source: 0001209191-21-008276 · doc5.xml · nonDerivative · entry 17 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,323 Read SEC document |
| October 22, 2020 Filed Feb 5, 2021 23:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.08 | $46.20 |
DisclosureSEC source: 0001209191-21-008276 · doc5.xml · nonDerivative · entry 16 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,308 Read SEC document |
| October 21, 2020 Filed Feb 5, 2021 23:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.04 | $45.60 |
DisclosureSEC source: 0001209191-21-008276 · doc5.xml · nonDerivative · entry 15 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,293 Read SEC document |
| October 20, 2020 Filed Feb 5, 2021 23:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.04 | $45.60 |
DisclosureSEC source: 0001209191-21-008276 · doc5.xml · nonDerivative · entry 14 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,278 Read SEC document |
| October 19, 2020 Filed Feb 5, 2021 23:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.03 | $45.45 |
DisclosureSEC source: 0001209191-21-008276 · doc5.xml · nonDerivative · entry 13 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,263 Read SEC document |
| October 16, 2020 Filed Feb 5, 2021 23:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.07 | $46.05 |
DisclosureSEC source: 0001209191-21-008276 · doc5.xml · nonDerivative · entry 12 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,248 Read SEC document |
| October 15, 2020 Filed Feb 5, 2021 23:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.07 | $46.05 |
DisclosureSEC source: 0001209191-21-008276 · doc5.xml · nonDerivative · entry 11 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,233 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.